Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
01-03 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Coatings TrendsCoatings Trends
Not Confirmed
Not Confirmed
03-05 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
01-03 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Coatings TrendsCoatings Trends
Industry Trade Show
Not Confirmed
03-05 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
28 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/28/3141119/0/en/atai-Life-Sciences-to-Participate-in-September-Investor-Conferences.html
14 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/14/3133317/0/en/atai-Life-Sciences-Reports-Second-Quarter-2025-Financial-Results-and-Recent-Corporate-Updates.html
29 Jul 2025
// BIOSPACE
https://www.biospace.com/drug-development/atai-partnered-schizophrenia-drug-flunks-mid-stage-trial
28 Jul 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/atais-schizophrenia-drug-fails-improve-cognition-phase-2-study
28 Jul 2025
// BIOSPACE
https://www.biospace.com/drug-development/atai-partnered-schizophrenia-drug-flunks-mid-stage-trial
25 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/25/3121996/0/en/Recognify-Life-Sciences-Provides-Update-on-Phase-2b-Trial-of-Inidascamine-in-Patients-with-Cognitive-Impairment-Associated-with-Schizophrenia.html
ABOUT THIS PAGE